Toggle Main Menu Toggle Search

Open Access padlockePrints

Node negative breast cancer: the prognostic value of DNA ploidy for long-term survival

Lookup NU author(s): Dr Ian Corbett, Dr Brian Shenton, Professor Thomas Lennard


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


The DNA content of breast tumours from 170 patients who presented between 1978 and 1980 was measured by flow cytometry. The relationship between tumour ploidy and disease outcome was assessed and its association with other prognostic factors evaluated. Compared with those with diploid tumours, patients with aneuploid tumours had significantly earlier relapse and shorter survival (P < 0.0001). Tumour ploidy was strongly related to grade (P < 0.001), but there was no significant association between DNA ploidy and c-erb-B-2 expression, lymph node status or tumour size. In lymph node negative and c-erb-B-2 negative patients, aneuploid tumours were associated with a poorer prognosis (P < 0.001) than diploid tumours. Multivariate analysis showed that tumour ploidy gave independent information on disease free and overall survival. Tumour ploidy may be used as an independent prognostic variable in patients with breast cancer and it may be helpful in defining patients within the node negative or c-erb-B-2 negative groups likely to have a poor outcome who might benefit from adjuvant treatment.

Publication metadata

Author(s): Yuan J, Hennessy C, Corbett IP, Dykin R, Givan AL, Shenton BK, Henry JA, Wright C, Lennard TWJ

Publication type: Article

Publication status: Published

Journal: British Journal of Surgery

Year: 1991

Volume: 78

Issue: 7

Pages: 844-848

Print publication date: 01/07/1991

ISSN (print): 0007-1323

ISSN (electronic): 1365-2168


DOI: 10.1002/bjs.1800780724


Altmetrics provided by Altmetric